SL Science Holding Limited Ordinary Shares
SLBTHealthcareNASDAQBiotechnology
Scan Results
Daily timeframeHeadquartered within the healthcare sector, SL Science Holding Limited Ordinary Shares focuses on Biotechnology services and products. SL Science Holding Limited manufactures cosmetic skin care and scalp care products. At a $3.57B market cap, SL Science Holding Limited Ordinary Shares ranks as a mid-cap company within healthcare. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series.
Market Cap
$3.57B
Beta
—
P/E (TTM)
—
P/E (Fwd)
—
EPS (TTM)
$-0.01
EPS (Fwd)
—
ROE
—
ROA
—
Cash
—
Total Debt
—
Free CF
—
52W Change
-37.5%
Annual Financials
Cash vs Debt
As with any equity investment, SLBT carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for SL Science Holding Limited Ordinary Shares and its sector.